SCHEMBL30898565

SCHEMBL30898565

CC(=O)c1ccc2cc(N(C)C)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.53
RAB9A P51151 5/20 0.53
NPC1 O15118 4/20 0.53
KDM4E B2RXH2 2/20 0.53
MAPK1 P28482 1/20 0.53
CYP2A6 P11509 1/20 0.52
HPGD P15428 5/20 0.50
ALDH1A1 P00352 4/20 0.50
KDM2B Q8NHM5 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TERT O14746 1/20 0.44
APP P05067 1/20 0.44
KCNK3 O14649 1/20 0.41
CYP1A2 P05177 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34895 1.00 MAPT (0.53) MAPTRAB9ANPC1KDM4EMAPK1
SCHEMBL13486847 0.86 MAPT (0.51) MAPTRAB9ANPC1KDM4EMAPK1
SCHEMBL13486855 0.86 MAPT (0.51) MAPTRAB9ANPC1KDM4EMAPK1
SCHEMBL29717125 0.85 KDM4E (0.55) MAPTRAB9ANPC1KDM4EHPGD
SCHEMBL2701032 0.85 KDM4E (0.55) MAPTRAB9ANPC1KDM4EHPGD
SCHEMBL1177340 0.84 CYP2A6 (0.47) MAPTRAB9ANPC1KDM4EMAPK1
SCHEMBL834744 0.83 CYP2A6 (0.68) MAPTRAB9ANPC1KDM4ECYP2A6
SCHEMBL30504311 0.83 LCK (0.56) MAPTRAB9ANPC1KDM4EHPGD
SCHEMBL28040989 0.83 HPGD (0.48) MAPTRAB9ANPC1KDM4EMAPK1
SCHEMBL13486851 0.82 APP (0.48) MAPTRAB9ANPC1KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024049924-A1 OPTICAL SYSTEMS AND PLATFORMS FOR SIMULTANEOUSLY ANALYZING MULTIPLE SOLUTION PROPERTIES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-03-07 WO claimed
US-20260056107-A1 OPTICAL SYSTEMS AND PLATFORMS FOR SIMULTANEOUSLY ANALYZING MULTIPLE SOLUTION PROPERTIES UNIV CALIFORNIA (US) 2026-02-26 US disclosed
WO-2024049924-A1 OPTICAL SYSTEMS AND PLATFORMS FOR SIMULTANEOUSLY ANALYZING MULTIPLE SOLUTION PROPERTIES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260056107-A1 OPTICAL SYSTEMS AND PLATFORMS FOR SIMULTANEOUSLY ANALYZING MULTIPLE SOLUTION PROPERTIES KIF11, HTT, NSF MAPT 6/4885RAB9A 152/4885NPC1 1213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.